Resistant hypertriglyceridemia in a patient with high plasma levels of apolipoprotein CII [1]

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 10, 2000, Pages 2329-

  Fornengo, P ^a   Bruno, A ^a   Gambino, R ^a   Cassader, M ^a   Pagano, G ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; APOLIPOPROTEIN C2; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; CHYLOMICRON; FENOFIBRATE; GAMMA GLUTAMYLTRANSFERASE; GEMFIBROZIL; GLYCOSAMINOGLYCAN; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ATHEROGENESIS; CASE REPORT; DIET THERAPY; HUMAN; HYPERTRIGLYCERIDEMIA; LETTER; LIPOPROTEIN DEFICIENCY; MALE; PRIORITY JOURNAL;

EID: 0033785581     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.10.2329     Document Type: Letter

References (5)

1. Lipid binding of apolipoprotein CII is required for stimulation of lipoprotein lipase activity against apolipoprotein CII-deficient chylomicrons
2. Construction and functional characterization of recombinant fusion proteins of human lipoprotein lipase and apolipoprotein CII
3. A G+ 1 to C mutation in a donor splice site of intron 2 in the apolipoprotein (apo) CII gene in a patient with apo CII deficiency: A possible interaction between apo CII deficiency and apo E4 in a severely hypertriglyceridemic patient
4. Overexpression of apolipoprotein CII causes hypertriglyceridemia in transgenic mice
5. Cofactor activity of protein components of human very low density lipoproteins in the hydrolysis of triglycerides by lipoproteins lipase from different sources